4//SEC Filing
Farnum Rhonda 4
Accession 0001415889-25-019869
CIK 0001583107other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 6:01 PM ET
Size
8.7 KB
Accession
0001415889-25-019869
Insider Transaction Report
Form 4
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Transactions
- Sale
Ordinary Shares
2025-07-14$11.39/sh−5,318$60,548→ 330,918 total - Sale
Ordinary Shares
2025-07-14$11.39/sh−682$7,770→ 336,236 total - Sale
Ordinary Shares
2025-07-14$11.39/sh−4,000$45,552→ 326,918 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices from $11.24 to $11.465 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices from $11.24 to $11.46 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001898490
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 6:01 PM ET
- Size
- 8.7 KB